chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain in the arm when he raises it up; feels like it's pulling his nerve; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (pain in the arm when he raises it up) and FEELING ABNORMAL (feels like it's pulling his nerve) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm when he raises it up) and FEELING ABNORMAL (feels like it's pulling his nerve). At the time of the report, PAIN IN EXTREMITY (pain in the arm when he raises it up) and FEELING ABNORMAL (feels like it's pulling his nerve) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitants - cholesterol medication, eyedrop, something for the nose. Treatment information as not reported.
This spontaneous prospective pregnancy report has been received from a 37 year old female consumer concerning herself with thyroid issue and no drug reactions. On 28-APR-2015 the patient was vaccinated with (Oka/Merck) VARIVAX, (strength, dose, lot number, expire date and route were not provided) for prevention of chickenpox. She also vaccinated with MMR II (strength, dose, lot number, expire date and route were not reported) concomitant. Concomitant therapies included a thyroid medication (unspecified name, dose/frequency and manufacturer). On an unknown date the patient had a pregnancy test which showed she became pregnant on 14-APR-2015. Her Last Menstrual Period (LMP) was 31-MAR-2015 and the Estimated Date of Delivery (EDD) was 05-JAN-2016. Initial exposure to (Oka/Merck) VARIVAX and MMR II was at 4 weeks. The pregnancy outcome was pending. The patient didn's seek medical attention. No treatment was given for adverse event. Additional information has been requested.
abdo pain, nausea, fever 104, seen in ER 6DEC94 recvd IV fluids, CBC, cXR, UA dx'd viral synd;
The injection hit a nerve in my shoulder that runs into my index finer and middle finger. I am still feeling it today 11/21/2023.
About 30 minutes after receiving her 2nd HPV (10/11) vaccine so came back to the department. Patient laid down with legs elevated & observed for about 40 min. Patient left the clinic without any symptoms. Seen by MD 2 days later reporting head pressure the evening of the day she received her vaccine; on 10/12 woke up feeling exhausted & slept most of the day. Also noted frequent twitching in her legs & shoulders; mild muscle aches & cold feeling as well. Only had a low grade fever with her first HPV vaccine. No treatment.
Taken from a clinical note in neurology. 11/04/2021 he had the Pfizer COVID-19 booster.  He had side effects including fever, chills, generalized achy, fatigue, and sleepiness for about 24 hours followed by improvement.  He had arm soreness on the side of the vaccination that has persisted to some degree.  He has had some reaction to all of the vaccinations. 11/11/2021 he developed itching in his hands and feet that intensified as the day went on.  By the following day he had a sensation of coldness with tingling from the knees and elbows on down.  He was mildly unsteady.  He does not feel he was weak.  He was still able to walk.  Symptoms persisted for days and then gradually began to resolve.  Over the weekend began to feel much better.  Today he has some mild residual feeling of coldness in his feet.  Yesterday was the best he has felt since 11/11/2021.  He has never had anything like this happen to him before.  During this time he developed constipation.  He did not develop dry eyes, dry mouth, orthostatic intolerance, tachycardia, abdominal symptoms, or other systemic constitutional symptoms.  Overall his baseline vertigo symptoms remained about the same. The paresthesias may have been somewhat positional.  When he was standing and walking in busy he could be distracted from them during the day.  They tended to be more noticeable when he was sitting with a flexed spinal posture.  He felt better laying flat in bed verses curled up on his side.  He did not have a classic Lhermitte's. Emergency department presentation 11/16/2021 documented normal reflexes gait and Romberg. CLARIFICATION OF QUESTION BELOW: He has largely recovered with minimal persistent tingling symptoms limited to hands and feet at per 12/2/2021
This spontaneous report was received from a healthcare worker and refers to a 26 year old patient of unknown age and gender. There was no information about patient's concomitant medications, pertinent medical history, drug reactions or allergies provided. On 31-AUG-2015, the patient was vaccinated with expired dose of (Oka/Merck) VARIVAX (lot# reported as J005723, expiration date 08-MAY-2015, dose, site and route of administration were not reported). The patient had not experienced an adverse effect. Additional information has been requested.
Large red rash on (L) arm at site of injection, diameter 3" to 4" swelling, edema, itching and area "hot" to touch. Treatment 5 dys KEFLEX 250 mg & Methylprednisone tablets 4 mg (Mfr Sanofi 6 dys 21 tablets pack has lasted to date 4 1/2 week & appears to be resolving.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 29-NOV-2007, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles. In 2008, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown.  Causality assessment was related. Additional information has been requested.
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown demographics. Pertinent medical history and concomitant medications were not reported. On an unknown date the patients were vaccinated with improperly stored VARIVAX (Merck). No symptoms were reported. The outcome of the events was unknown. The case is linked to MARRS# 1502USA004127 (same reporter link). Additional information has been requested.
pt vaxed w/HBOC on 16MAR93; w/in 2 hrs devel fever & was seen by MD; hospitlaized next day dx meningitis secondary to H. influenzae type b; pt recovered & was discharged in 11 days;
Severe chills, extreme dizziness, faint, felt like the worst days of my Covid infection.    Outcome, other than fatigue, fine within 24 hours.   For your information, I have never had an adverse reaction to vaccines, including pneumonia, shingles,etc.   I am filing this primarily because I know there isn't a great deal of information about adverse reactions of previously infected Covid patients.
Had poor appetite and some fussiness for 3 days after immunizations. On evening of 02/25/2005, Tayla began non-stop crying for 3 hours, fever of 101-102 degrees, high pitch crying and irritablility. Tylenol given every 4 hours for several days. To ER on 02/27/2005. No diagnosis.
Swelling in the arm; This spontaneous case was reported by a physician and describes the occurrence of PERIPHERAL SWELLING (Swelling in the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swelling in the arm). At the time of the report, PERIPHERAL SWELLING (Swelling in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Non significant follow up: Contact details updated
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old patient received BNT162b2 (BNT162B2), on 19Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 09Feb2021 as dose 2, single (Batch/Lot number: unknown), in left arm, on 14Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 31Mar2022 at 16:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 71 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Atrial flutter" (unspecified if ongoing). Concomitant medication(s) included: ROSUVASTATIN, start date: Dec2017, stop date: 13Jun2022; XARELTO, start date: Mar2022, stop date: 13Jun2022.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: (21Jun2022) Negative, notes: Symptoms resolved, and tested negative for COVID-19 antibodies; (23Jun2022) Positive, notes: Symptoms returned, and tested positive for COVID-19 antibodies. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Patient recieved anti viral Paxlovid from 15Jun2022 to 19Jun2022 for treatment of COVID-19. Symptoms resolved, and tested negative for COVID-19 antibodies, 2 days after completion of Paxlovid treatment. Symptoms returned, and tested positive antibodies for COVID-19 on 23Jun2022, 5 days after completion of Paxlovid treatment. No known allergies reported.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information has been received from a RN and follow up information from a nurse practitioner concerning a pt (age and gender not reported) who in 2004 (exact date not specified) was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot647797/0987N). Subsequently, the pt experienced injection site reaction with raised hot area at site and fever. Unspecified medical attention was sought. The pt was treated with diphenhydramine hydrochloride (Benadryl). The nurse practitioner reported she had no further specific details for the case. She did however report that the pt's physician did not feel that these reactions were related to the pneumococcal 23v polysaccharide vaccine. The nurse also reported an approx 50 yr old female pt experienced injection site reaction, raised hot area on arm, temp, malaise, poor appetite and felt ill after vaccination with pneumococcal 23v polysaccharide vaccine (lot 647797/0987N) (WAES0409USA01176) and a male pt experienced injection site reaction with raised hot area at site and fever (WAES0409USA01642). Additional information has been requested.
Received vaccine smallpox on 09/17/2003.  Arrived in Africa 09/22.  11/04, has 4 day complaints of confluent papular/pustular pruritic rash bilateral arms, legs, face, mouth.  No F/C.
pt recv vax & 5min later hives lt legs & diffuse red rash abd & rt leg;epi given w/resolve of rash;sent to ER where DPH was given;
Only sore arm initially.  1/16/21 she developed redness heat and swelling at site. no fever. treated with ice  and ibuprofen. she takes zyrtec daily for allergies. condition improved by time of evaluation 1/22/2021- fading redness, no heat
Pt stopped talking, become spacey and stopped responding. per doc 212752 patient has never developed appropriate speech language communication. He was right on track before the vaccines. His intestinal system is still messed-up and he is now on undergoing treatment to rid his body of mercury and other toxins. *F/UP report on 3/21/03: Autistic Sx's, Severe language loss.*
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment information was reported.   Reporter did not allow further contact
Patient stated that she became dizzy, weak, started to become cold, and she could feel her heart rate increasing.  Patient was assessed and vitals were found to be in normal limit.
10 days after the vaccine, I developed a very large rash on the back of my right shoulder and rash on the calf of my right leg. The rash was red, very itchy and in a circular pattern. I did take Benadryl cream which did not help at all. I did go see a dermatologist and I was prescribed a steroid cream (triamcinolone) which did not improve the rash. I was also getting more spotty rashes on legs, back of arms and back of shoulders. I went back to the dermatologist who took a biopsy of one of the spotty rash. The biopsy results found that it was a reaction to a medication. I was still having severe itching and made an appointment with an specialist/allergist on 3/17/2021. The allergist felt very strongly that it was a reaction to the vaccine. I was prescribed a stronger steroid cream (Clobetasol) twice a day, Claritin pills 4 times a day for 1 month, which resolved my rash. I had this rash for 3 months and after seeing the allergist and doing a second round of medications, the rash has resolved.
Vaccine admin on 4/20/2006. Death from apnea/bradycardia reportedly on 4/23/2006. I do not have details. 6/1/06 Received medical records from hospital which reveal patient had been readmitted to hospital 3/28/06 after having been transferred to university med center for bronchoscopy & trach placement 3/17/06.  Concurrent dx: GERD, retinopathy of preemie, left hydrocele and perianal excoriations, anemia, PDA, pulmonary HTN & hyperbilirubinemia.  Patient had continued occasional desaturation spells & occasional chronic lung disease shutdown spells but was felt to be stable overall.  D/C from hospital 4/18/06 w/final dx: preemie, chronic lung disease, persistent apnea, subglottic stenosis s/p trach, HTN, retinopathy of preemie, bilateral hydrocele/ss
This is a spontaneous report from a contactable consumer (patient's husband). A female patient of unknown age and ethnicity received a single dose PREVNAR 13 in 2015 (Oct or Nov) for immunization.  The patient medical history included asthma and a form of Parkinson's/dystonia. Concomitant medications included fluticasone propionate, ADVAIR and corticosteroid for asthma. On an unspecified date the patient experienced coughing; she was not coughing prior to receiving the vaccine. The outcome of coughing was not recovered. She also developed short of breath on an unspecified date with outcome of unknown. Follow-up (03Oct2016): New information obtained from a contactable consumer (patient's husband) includes: new event short of breath.
stomach pain; top of shoulder aches the radiates up to the neck like toothache; Chills; Fever; muscles hurts all over; joints hurts all over; muscle soreness in the arm at vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain), PAIN (top of shoulder aches the radiates up to the neck like toothache), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (muscles hurts all over) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach pain), PAIN (top of shoulder aches the radiates up to the neck like toothache), CHILLS (Chills), PYREXIA (Fever), MYALGIA (muscles hurts all over), ARTHRALGIA (joints hurts all over) and VACCINATION SITE PAIN (muscle soreness in the arm at vaccination site). At the time of the report, ABDOMINAL PAIN UPPER (stomach pain), PAIN (top of shoulder aches the radiates up to the neck like toothache), CHILLS (Chills), PYREXIA (Fever), MYALGIA (muscles hurts all over), ARTHRALGIA (joints hurts all over) and VACCINATION SITE PAIN (muscle soreness in the arm at vaccination site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
7x7 cm red/mild swelling/mild tender local petechiae/rash at vaccine area x 3 days.
Rapid heartbeat and fever starting 18 hours post vaccine and lasting for another 36 hours.)
received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a infant patient who received Hib (Hiberix) (batch number 242A7) for prophylaxis.   On 03-FEB-2023, the patient received Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
From initial information received on 22Oct04 from a RN regarding an adverse event occurring, it was reported that a 40 year old female pt received her first dose of Menomune A/C/Y/W-135, lot number UE348AA, administered SC in the left arm on 20Oct04. She also received her first dose of Pneumonia vaccine, lot number 0986N, administered intramuscularly in the left deltoid on 21Oct04 at 3:45PM. At 5:00PM on 21Oct04, the pt developed hives on upper arms, legs, chest and eye lids. Per pt, she did not develop shortness of breath or any other symptoms. Reportedly, the symptoms mostly resolved the following morning on 22Oct04 and completely resolved by 11:00AM. Pt's pre-existing medicl conditions include hypothyroidism, Hashimoto's  and angioedema. At the time of vaccination, the pt also took Atenolol, Levoxyl and Epipen. She had no illnesses at the time of vaccination.
In observation area, patient reported sharp pain in left arm at 0956 to lead nurse. Lead nurse assessed patient. Patient denied difficulty breathing, chest pain, and throat irritation. Patient reported history of similar reactions to prior vaccines. Patient's mother reported to lead nurse that the patient's has a history of similar reactions to prior vaccinations and that the symptom resolves on its own. Patient offered EMS. Patient denied EMS. Patient advised to stay 15 minutes for further observation. Lead nurse heard patient's mother ask patient if she wanted to go to  Medical Center. Patient agreed to go to  Medical Center. Patient left facility with mother at 1010 with steady gait and unlabored breathing.
achy; tired; This case was reported by a consumer via call center representative and described the occurrence of pain in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain and tiredness. On an unknown date, the outcome of the pain and tiredness were unknown.   It was unknown if the reporter considered the pain and tiredness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that, her friends experienced achy and tiredness after vaccination with 2nd dose of Shingrix. No additional details were provided. The reporter did not consent to follow up. This case has been linked with cases US2020000911, US2020000907, US2020000901, reported by same reporter.
Pain immediately and later persistently in (L) shoulder, particularly with ant flexion and flexion with internal rotation.
This spontaneous report was received from a pharmacist via company representative and refers to a unspecified number of patients of unknown age. On an unknown date, the patients started the HPV series with GARDASIL (dose and anatomical location were not reported). The reporter stated, that some of the pediatric clinics (unspecified) on an unknown date had been administering GARDASIL 9 (dose, dose number and anatomical location were not reported) to complete the HPV series. No adverse event was reported. This is one of several reports from the same reporter. Additional information has been requested.
Rash around the injection site.  Iced by the vaccine recipient.  Itching quickly subsided and the rash gradually faded in about a week.   Other than soreness at the injection site on day 2, there were no side effects other than the rash.  No rash encounted with the second Moderna injection on 4/6/2021.  With the second Moderan injection there was soreness at the injection site and minor aches the following day.  Day 3 was fine.
This spontaneous report as received from registered nurse refers to unspecified patients of unknown ages and genders who on unknown date in January 2015 (reported as since 21-JAN-2015) were vaccinated with a dose of PNEUMOVAX 23, intramuscular (dose, lot # and expiration date were not reported) which underwent a supported temperature excursion. No adverse effects were reported. It was unknown if the patients sought medical attention. This is one of several reports from the same source. Additional information has been requested.